In the winter 2015 round of the Early Stage Commercialization Fund (ESCF), Innovacorp is offering additional funding specifically for the commercialization of Emerging Medical Technologies and Therapeutics (EMTT).
Medical technologies eligible for this program include areas such as medical devices, digital health, imaging and diagnostics. Therapeutics include small molecule drugs and biologics. (Eligible digital health products need to qualify as a medical device from a regulatory perspective. Electronic health record applications are excluded.)
Successful ESCF-EMTT applicants will receive funding of up to $100,000 and expert mentoring support. Funds are non-repayable and project duration is up to 18 months. Project proposals are due Friday, February 6, 2015.
Our regular ESCF round is also running this winter, but the deadline is the following week.